Antibody Characterization Report for ACSL5 (Long-chain-fatty-acid--CoA ligase 5)
Antibody Characterization Report for ACSL5 (Long-chain-fatty-acid--CoA ligase 5)
This report presents a guide to selecting high-quality commercial antibodies against Long-chain-fatty-acid--CoA ligase 5 (ACSL5) by western blot, immunoprecipitation and immunofluorescence, using a standardized experimental protocol comparing read-outs in knockout cell lines and isogenic parental controls. This study was funded in part by the ALS-Reproducible Antibody Platform (ALS-RAP), established as a public-private partnership by three prominent ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.
- Montreal Neurological Institute and Hospital Canada
- University of Toronto Canada
- Structural Genomics Consortium Brazil
- McGill University Canada
ACSL5, Q9ULC5, western blot, antibody characterization, Amyotrophic Lateral Sclerosis, Long-chain-fatty-acid--CoA ligase 5, immunofluorescence, antibody validation, immunoprecipitation
ACSL5, Q9ULC5, western blot, antibody characterization, Amyotrophic Lateral Sclerosis, Long-chain-fatty-acid--CoA ligase 5, immunofluorescence, antibody validation, immunoprecipitation
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!